The impact of COVID-19 on pulmonary, neurological, and cardiac outcomes: evidence from a Mendelian randomization study
Frontiers in Public Health · 2023
DOI: 10.3389/fpubh.2023.1303183 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Public Health, 2023. Verfasst von Pooja U Shenoy und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Data Analytics, Bioinformatics and Structural Biology, Yenepoya Research Centre, Yenepoya (Deemed to be University), Mangalore, India. Hauptthemen laut MEDLINE: COVID-19, Fatigue Syndrome, Chronic, Parkinson Disease, Heart Failure. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Long COVID is a clinical entity characterized by persistent health problems or development of new diseases, without an alternative diagnosis, following SARS-CoV-2 infection that affects a significant proportion of individuals globally. It can manifest with a wide range of symptoms due to dysfunction of multiple organ systems including but not limited to cardiovascular, hematologic, neurological, gastrointestinal, and renal organs, revealed by observational studies. However, a causal association between the genetic predisposition to COVID-19 and many post-infective abnormalities in long COVID remain unclear.
Methods
Here we employed Mendelian randomization (MR), a robust genetic epidemiological approach, to investigate the potential causal associations between genetic predisposition to COVID-19 and long COVID symptoms, namely pulmonary (pneumonia and airway infections including bronchitis, emphysema, asthma, and rhinitis), neurological (headache, depression, and Parkinson’s disease), cardiac (heart failure and chest pain) diseases, and chronic fatigue. Using two-sample MR, we leveraged genetic data from a large COVID-19 genome-wide association study and various disorder-specific datasets.
Results
This analysis revealed that a genetic predisposition to COVID-19 was significantly causally linked to an increased risk of developing pneumonia, airway infections, headache, and heart failure. It also showed a strong positive correlation with chronic fatigue, a frequently observed symptom in long COVID patients. However, our findings on Parkinson’s disease, depression, and chest pain were inconclusive.
Conclusion
Overall, these findings provide valuable insights into the genetic underpinnings of long COVID and its diverse range of symptoms. Understanding these causal associations may aid in better management and treatment of long COVID patients, thereby alleviating the substantial burden it poses on global health and socioeconomic systems.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Data Analytics, Bioinformatics and Structural Biology, Yenepoya Research Centre, Yenepoya (Deemed to be University), Mangalore, India.
- Department of Community Medicine, Yenepoya Medical College and Hospital, Yenepoya (Deemed to be University), Mangalore, India.
- Department of Statistics, Yenepoya (Deemed to be University), Mangalore, India.
- Department of Medical Genetics, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, India.
Zitieren
APA
Shenoy, P. U., Udupa, H., Ks, J., Babu, S., K, N., Jain, N., Das, R., & Upadhyai, P. (2023). The impact of COVID-19 on pulmonary, neurological, and cardiac outcomes: evidence from a Mendelian randomization study. Frontiers in Public Health. https://doi.org/10.3389/fpubh.2023.1303183
Vancouver
Shenoy PU, Udupa H, Ks J, Babu S, K N, Jain N, et al. The impact of COVID-19 on pulmonary, neurological, and cardiac outcomes: evidence from a Mendelian randomization study. Frontiers in Public Health. 2023. doi:10.3389/fpubh.2023.1303183
BibTeX
@article{Shenoy2023,
author = {Shenoy, Pooja U and Udupa, Hrushikesh and Ks, Jyothika and Babu, Sangeetha and K, Nikshita and Jain, Neha and Das, Ranajit and Upadhyai, Priyanka},
title = {The impact of COVID-19 on pulmonary, neurological, and cardiac outcomes: evidence from a Mendelian randomization study},
journal = {Frontiers in Public Health},
year = {2023},
doi = {10.3389/fpubh.2023.1303183}
}
EUVIMED